MAPT and Alzheimer disease: Clinical evidence and experimental studies indicate an imbalance between Aβ production and clearance as the upstream event of Aβ dysregulation, which plays a critical role in AD onset, and leads to the formation of neurofibrillary tangles of tau protein, vascular damage, and neuronal loss (Selkoe & Hardy, 2016; Jeremic et al., 2021).